IM Cannabis (IMCC) Total Liabilities (2019 - 2026)
IM Cannabis' (IMCC) quarterly Total Liabilities came in at $21.0 million in Q1 2026, down 27.78% year-on-year from $29.1 million in Q1 2025, and down 17.08% quarter-over-quarter from $25.3 million in Q4 2025.
IM Cannabis (IMCC) Total Liabilities (2019 - 2026) Analysis & Trends
IM Cannabis' Total Liabilities history runs 8 years deep, the most recent figure standing at $21.0 million for Q1 2026.
- On a quarterly basis, Total Liabilities fell 27.78% year-over-year to $21.0 million in Q1 2026; TTM through Mar 2026 was $21.0 million, a 27.78% decrease from a year earlier, with the FY2025 full-year figure at $25.3 million, down 3.7% from the prior year.
- Total Liabilities slipped to $21.0 million in Q1 2026 per IMCC's latest filing, from $25.3 million in the prior quarter.
- Across five years, Total Liabilities topped out at $65.3 million in Q1 2022 and bottomed at $21.0 million in Q1 2026.
- The 5-year median for Total Liabilities is $25.8 million (2024), against an average of $32.0 million.
- Across the five-year window, Total Liabilities plunged 63.48% in 2022 and advanced 21.97% in 2024, its largest moves.
- Year by year, Total Liabilities stood at $27.2 million in 2022, then decreased by 5.07% to $25.8 million in 2023, then gained by 0.03% to $25.8 million in 2024, then declined by 1.75% to $25.3 million in 2025, then fell by 17.08% to $21.0 million in 2026.
- Per Business Quant, the three latest IMCC Total Liabilities figures stand at $21.0 million (Q1 2026), $25.3 million (Q4 2025), and $29.1 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 21.48 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 31.81 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 11.92 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 51.53 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 813.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 13.17 Bn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 22.18 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 1.50 Bn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 6.72 Bn |
| 10 | IM Cannabis | 591,792.44 | -193,562.09 | 1.03 Mn | 21.02 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 21.02 Mn |
| Dec 31, 2025 | 25.35 Mn |
| Sep 30, 2025 | 29.09 Mn |
| Jun 30, 2025 | 26.71 Mn |
| Mar 31, 2025 | 29.10 Mn |
| Dec 31, 2024 | 25.80 Mn |
| Sep 30, 2024 | 29.63 Mn |
| Jun 30, 2024 | 25.40 Mn |
| Mar 31, 2024 | 24.32 Mn |
| Dec 31, 2023 | 25.79 Mn |
| Sep 30, 2023 | 24.30 Mn |
| Jun 30, 2023 | 25.47 Mn |
| Mar 31, 2023 | 23.85 Mn |
| Dec 31, 2022 | 27.17 Mn |
| Sep 30, 2022 | 56.04 Mn |
| Jun 30, 2022 | 59.42 Mn |
| Mar 31, 2022 | 65.30 Mn |
| Dec 31, 2021 | 37.41 Mn |
| Sep 30, 2021 | 51.17 Mn |
| Jun 30, 2021 | 162.73 Mn |